The recent arrival of this new formulation represents a possibly significant advancement in the handling of type 2 the illness. This therapy builds upon the prior success of lower amounts, showing impressive results in lowering blood glycemic control and promoting a decrease in weight. Researchers are exploring its overall impact on heart outcomes